Parker Moss is Chief Commercial Officer for Genomics England, a Department of Health organisation focussed on driving Genomic Medicine into the NHS, and accelerating Genomic research in industry and academia. Parker is responsible for the organisation’s strategic relationships in the Biopharma Sector, the NHS and Academia. Previously Parker served as a member of the executive team at Owkin, an AI/ML Cancer Research company focussed on federated learning. Parker was a CTO in the NHS, including technology leadership roles at Great Ormond Street and Virgin Care. He worked at F-Prime and EightRoads, Fidelity-backed VC funds and led the investment in Owkin before joining the company. Parker also holds several non-executive roles, including Membership on the Secretary of State's technology advisory board, and member of Cancer Research UK's commercial board. Parker holds a degree in Physics and Philosophy from Durham University. Outside of work his passion is classical music.